NP / PA
Hicks-Robertson, Jessica
Hicks-Robertson, Jessica was paid $249K by Medicaid between May 2018 and Nov 2024, across 21 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 78% of everything it billed.
33Billing provider infoHICKS-ROBERTSON, JESSICA
MOOREVILLE, MS 38857
MOOREVILLE, MS 38857
33aNPI1306211164assigned 12/04/2015
33bProvider typeFamily Nurse Practitioner
28Total paid$249K
24GClaims10,386
24DCodes billed21
24AFirst – last monthMay 2018 – Nov 2024
Compared with peers
Next to other Family Nurse Practitioner providers in Mississippi
Rank by total paid#39 of 206
Median peer was paid$22K
This provider vs. median11×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 1,696 | $47K | |
| 2019 | 2,281 | $76K | |
| 2020 | 1,042 | $38K | |
| 2021 | 1,997 | $29K | |
| 2022 | 1,573 | $25K | |
| 2023 | 1,209 | $22K | |
| 2024incomplete | 588 | $13K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 78% | 3,912 | 2,838 | $194K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 7.5% | 2,067 | 1,646 | $19K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 4.2% | 307 | 226 | $11K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 2.6% | 509 | 364 | $6K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 2.3% | 607 | 534 | $6K |
| 99051 | 2.1% | 410 | 313 | $5K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 1.7% | 423 | 301 | $4K |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 575 | 392 | $2K |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | <1% | 30 | 26 | $2K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 13 | 13 | $474.00 |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | <1% | 16 | 12 | $234.64 |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 20 | 14 | $101.01 |
9 more codes
| 36415 | Collection of venous blood by venipuncture | <1% | 49 | $97.85 |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 67 | $85.70 |
| 86308 | <1% | 17 | $83.34 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 150 | $42.79 |
| 81003 | <1% | 19 | $29.12 | |
| A4208 | Syringe with needle, sterile 3 cc, each | <1% | 446 | $2.10 |
| 36416 | 0% | 33 | $0.00 | |
| 99000 | 0% | 17 | $0.00 | |
| 99072 | 0% | 699 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.